Measles control and the prospect of eradication

Current Topics in Microbiology and Immunology

Volumn 330, Issue , 2009, Pages 173-189

  Moss, W J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MATERNAL ANTIBODY; MEASLES VACCINE; RETINOL;

BACTERIAL PNEUMONIA; BIOLOGICAL WARFARE; BUDGET; DEMOGRAPHY; DRUG SAFETY; ERADICATION THERAPY; FATALITY; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; MEASLES; MEASLES VACCINATION; MORTALITY; PANDEMIC; POLITICAL SYSTEM; POPULATION GROWTH; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SINGLE DRUG DOSE; VIRAL CONJUNCTIVITIS; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

HUMANS; IMMUNIZATION; INFECTION CONTROL; MEASLES; MEASLES VACCINE; POPULATION SURVEILLANCE; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 58249118055     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-70617-5_9     Document Type: Review

References (78)

1. Amanna IJ, Carlson NE, Slifka MK (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357:1903-1915
2. Andrews N, Tischer A, Siedler A, Pebody RG, Barbara C, Cotter S, Duks A, Gacheva N, Bohumir K, Johansen K, Mossong J, Ory F, Prosenc K, Slacikova M, Theeten H, Zarvou M, Pistol A, Bartha K, Cohen D, Backhouse J, Griskevicius A (2008) Towards elimination: measles susceptibility in Australia and 17 European countries. Bull World Health Organ 86:197-204
3. Angel JB, Walpita P, Lerch RA, Sidhu MS, Masuredar M, DeLellis RA, Noble JT, Snydman DR, Udem SA (1998) Vaccine-associated measles pneumonitis in an adult with AIDS. Ann Intern Med 129:104-106
4. Bellini WJ, Helfand RF (2003) The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 187 [Suppl 1]:S283-S290
5. Biellik R, Madema S, Taole A, Kutsulukuta A, Allies E, Eggers R, Ngcobo N, Nxumalo M, Shearley A, Mabuzane E, Kufa E, Okwo-Bele JM (2002) First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 359:1564-1568
6. Centers for Disease Control (1997) Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and the CDC. MMWR 46:1-20
7. Centers for Disease Control (2000) Measles outbreak - Netherlands, April 1999 - January 2000. MMWR Morb Mortal Wkly Rep 49:299-303
8. Centers for Disease Control and Prevention (2005) Global Measles and Rubella Laboratory Network, January 2004-June 2005. MMWR Morb Mortal Wkly Rep 54:1100-1104
9. Centers for Disease Control and Prevention (2007) Vaccination coverage among children in kindergarten - United States, 2006-07 school year. MMWR Morb Mortal Wkly Rep 56:819-821
10. Centers for Disease Control and Prevention (2008a) Multistate measles outbreak associated with an international youth sporting event - Pennsylvania, Michigan, and Texas, August-September 2007. MMWR Morb Mortal Wkly Rep 57:169-173
11. Centers for Disease Control and Prevention (2008b) Outbreak of measles - San Diego, California, January-February 2008. MMWR Morb Mortal Wkly Rep 57:203-206
12. Centers for Disease Control and Prevention (2008c) Progress toward measles mortality reduction and elimination - Eastern Mediterranean Region, 1997-2007. MMWR Morb Mortal Wkly Rep 57:262-267
13. Cohen JE (2003) Human population: the next half century. Science 302:1172-1175
14. Connolly MA, Gayer M, Ryan MJ, Salama P, Spiegel P, Heymann DL (2004) Communicable diseases in complex emergencies: impact and challenges. Lancet 364:1974-1983
15. Costa A, Henao-Restrepo AM, Hall SM, Jarrett S, Hoekstra EJ (2003) Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts. J Infect Dis 187 [Suppl 1]:S22-S28
16. Cutts FT, Steinglass R (1998) Should measles be eradicated? BMJ 316:765-767
17. Dowdle WR, Hopkins DR (1998) The eradication of infectious diseases: report of the Dahlem Workshop on the eradication of infectious diseases, Berlin, March 16-22, 1997. Wiley, New York
18. D'Souza RM, D'Souza R (2002) Vitamin A for the treatment of children with measles - a systematic review. J Trop Pediatr 48:323-327
19. Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P (2004) Cost-effectiveness of three different vaccination strategies against measles in Zambian children. Vaccine 22:475-484
20. de Quadros CA (2004) Can measles be eradicated globally? Bull World Health Organ 82:134-138
21. de Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, Alleyne GA (1996) Measles elimination in the Americas. Evolving strategies. JAMA 275:224-229
22. de Quadros CA, Izurieta H, Venczel L, Carrasco P (2004) Measles eradication in the Americas: progress to date. J Infect Dis 189 [Suppl 1]:S227-S235
23. DeStefano F, Thompson WW (2004) MMR vaccine and autism: an update of the scientific evidence. Expert Rev Vaccines 3:19-22
24. Dine MS, Hutchins SS, Thomas A, Williams I, Bellini WJ, Redd SC (2004) Persistence of vaccine-induced antibody to measles 26-33 years after vaccination. J Infect Dis 189 [Suppl 1]:S123-S130
25. Duke T, Mgone CS (2003) Measles: not just another viral exanthem. Lancet 361:763-773
26. Dye C (2008) Health and urban living. Science 319:766-769
27. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE (2000) Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 284:3145-3150
28. Frank SA, Bush RM (2007) Barriers to antigenic escape by pathogens: trade-off between reproductive rate and antigenic mutability. BMC Evol Biol 7:229
29. Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y (1998) Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280:527-532
30. Gay NJ (2004) The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis 189 [Suppl 1]:S27-S35
31. Gomi H, Takahashi H (2004) Why is measles still endemic in Japan? Lancet 364:328-329
32. Gounder C (1998) The progress of the Polio Eradication Initiative: what prospects for eradicating measles? Health Policy Plan 13:212-233
33. Grais RF, Conlan AJ, Ferrari MJ, Djibo A, Le Menach A, Bjornstad ON, Grenfell BT (2008) Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface 5:67-74
34. Helfand RF, Moss WJ, Harpaz R, Scott S, Cutts F (2005) Evaluating the impact of the HIV pandemic on measles control and elimination. Bull World Health Organ 83:329-337
35. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ (2003) Measles outbreaks in a population with declining vaccine uptake. Science 301:804
36. Kamugisha C, Cairns KL, Akim C (2003) An outbreak of measles in Tanzanian refugee camps. J Infect Dis 187 [Suppl 1]:S58-S62
37. Katz SL (2006) Polio: new challenges in 2006. J Clin Virol 36:163-165
38. Low N, Kraemer S, Schneider M, Restrepo AM (2008) Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis. Vaccine 26:383-398
39. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347:1477-1482
40. McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH (2007) Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis 196:1459-1464
41. Meissner HC, Strebel PM, Orenstein WA (2004) Measles vaccines and the potential for worldwide eradication of measles. Pediatrics 114:1065-1069
42. Monafo WJ, Haslam DB, Roberts RL, Zaki SR, Bellini WJ, Coffin CM (1994) Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr 124:273-276
43. Morgan OW (2004) Following in the footsteps of smallpox: can we achieve the global eradication of measles? BMC Int Health Hum Rights 4:1
44. Moss WJ, Griffin DE (2006) Global measles elimination. Nat Rev Microbiol 4:900-908
45. Moss WJ, Cutts F, Griffin DE (1999) Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis 29:106-112
46. Moss WJ, Monze M, Ryon JJ, Quinn TC, Griffin DE, Cutts F (2002) Prospective study of measles in hospitalized human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis 35:189-196
47. Moss WJ, Scott S, Mugala N, Ndhlovu Z, Beeler JA, Audet SA, Ngala M, Mwangala S, Nkonga-Mwangilwa, Ryon JJ, Monze M, Kasolo F, Quinn TC, Cousens S, Griffin DE, Cutts FT (2007) Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis 196:347-355
48. Offit PA, Coffin SE (2003) Communicating science to the public: MMR vaccine and autism. Vaccine 22:1-6
49. Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL (2000) Measles eradication: is it in our future? Am J Public Health 90:1521-1525
50. Otten M, Kezaala R, Fall A, Masresha B, Martin R, Cairns L, Eggers R, Biellik R, Grabowsky M, Strebel P, Okwo-Bele JM, Nshimirimana D (2005) Public-health impact of accelerated measles control in the WHO African Region 2000-03. Lancet 366:832-839
51. Pan American Health Organization (1999) Measles eradication. Field guide. Washington, DC, Pan American Health Organization
52. Parker AA, Staggs W, Dayan GH, Ortega-Sanchez IR, Rota PA, Lowe L, Boardman P, Teclaw R, Graves C, LeBaron CW (2006) Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 355:447-455
53. Permar SR, Moss WJ, Ryon JJ, Monze M, Cutts F, Quinn TC, Griffin DE (2001) Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis 183:532-538
54. Salama P, Assefa F, Talley L, Spiegel P, van Der V, Gotway CA (2001) Malnutrition, measles, mortality, and the humanitarian response during a famine in Ethiopia. JAMA 286:563-571
55. Schimmer B, Ihekweazu C (2006) Polio eradication and measles immunisation in Nigeria. Lancet Infect Dis 6:63-65
56. Scott S, Moss WJ, Cousens S, Beeler JA, Audet SA, Mugala N, Quinn TC, Griffin DE, Cutts FT (2007) The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 45:1417-1424
57. Scott S, Mossong J, Moss WJ, Cutts FT, Cousens S (2008) Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model. Int J Epidemiol 37:356-367
58. Sencer DJ, Dull HB, Langmuir AD (1967) Epidemiologic basis for eradication of measles in 1967. Public Health Rep 82:253-256
59. Senessie C, Gage GN, von Elm E (2007) Delays in childhood immunization in a conflict area: a study from Sierra Leone during civil war. Confl Health 1:14
60. Stone R (2002) Smallpox. WHO puts off destruction of U.S., Russian caches. Science 295:598-599
61. Takahashi H, Saito H (2008) Measles exportation from Japan to the United States, 1994 to 2006. J Travel Med 15:82-86
62. Tangermann RH, Hull HF, Jafari H, Nkowane B, Everts H, Aylward RB (2000) Eradication of poliomyelitis in countries affected by conflict. Bull World Health Organ 78:330-338
63. Tejiokem MC, Gouandjika I, Beniguel L, Zanga MC, Tene G, Gody JC, Njamkepo E, Kfutwah A, Penda I, Bilong C, Rousset D, Pouillot R, Tangy F, Baril L (2007) HIV-infected children living in central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization. PLoS ONE:e1260
64. United Nations, Department of Economic and Social Affairs Population Division (2007) World population prospects: the 2006 revision, highlights. United Nations, New York
65. United Nations Population Fund (2007) State of the world population 2007: unleashing the potential of urban growth. United Nations Population Fund
66. Uzicanin A, Zhou F, Eggers R, Webb E, Strebel P (2004) Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa. Vaccine 22:3419-3426
67. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637-641
68. Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS (2007) Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 369:191-200
69. Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele JM (2008) Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ 86:27-39
70. World Health Organization (2004) Measles vaccines. Wkly Epidemiol Rec 79:130-142
71. World Health Organization (2005) Progress in reducing measles mortality - worldwide 1999-2003. Weekly Epidemiol Rec 80:78-81
72. World Health Organization (2006a) Global distribution of measles and rubella genotypes - update. Wkly Epidemiol Rec 81:474-479
73. World Health Organization (2006b) Impact of measles control activities in the WHO African Region, 1999-2005. Wkly Epidemiol Rec 81:365-371
74. World Health Organization (2007a) Expanded Programme on Immunization of the Department of Immunization, Vaccines and Biologicals. WHO vaccine-preventable diseases: monitoring system. 2007 global summary. WHO/IVB/2007. World Health Organization, Geneva
75. World Health Organization (2007b) Progress in global measles control and mortality reduction, 2000-2006. Wkly Epidemiol Rec. 82:418-424
76. World Health Organization (2008) Immunization surveillance, assessment and monitoring. http://www.who.int/immunization-monitoring/diseases/measles/en/. Cited 28 May 2008. World Health Organization, Geneva
77. World Health Organization/United Nations Children's Fund (2001) Measles mortality reduction and regional elimination strategic plan 2001-2005. World Health Organization, Geneva
78. World Health Organization/United Nations Children's Fund (2005) Global Immunization Vision and Strategy 2006-2015. World Health Organization, Geneva